Fletcher Spaght, Inc.
32
13M
18
0.78
3
0.44
10
- Stages of investment
- Areas of investment
Summary
In 1983 was created Fletcher Spaght, Inc., which is appeared as VC. The company was established in North America in United States. The leading representative office of defined VC is situated in the Boston.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Software, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Proteus Digital Health, Juventas Therapeutics, Cayenne Medical.
The fund is constantly included in less than 2 deals per year. This Fletcher Spaght, Inc. works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 10 percentage points less often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2011. The top amount of exits for fund were in 2015.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Fletcher Spaght, Inc., startups are often financed by The Aurora Funds, Sevin Rosen Funds, Schroder Ventures. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, The Aurora Funds, New Enterprise Associates. In the next rounds fund is usually obtained by Silicon Valley Bank, New Enterprise Associates, Hatteras Venture Partners.
The fund was created by John Fletcher, Linda Tufts. We also calculated 7 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 32
- Lead investments
- 3
- Exits
- 10
- Rounds per year
- 0.78
- Follow on index
- 0.44
- Investments by industry
- Biotechnology (24)
- Medical (15)
- Health Care (13)
- Medical Device (13)
- Pharmaceutical (10) Show 17 more
- Investments by region
-
- United States (32)
- Peak activity year
- 2011
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 107M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 2.57
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Metabolon | 07 Dec 2009 | Biotechnology, Software, Health Diagnostics | Late Stage Venture | 6M | United States, North Carolina, Durham |
| SurgiQuest | 08 Jul 2011 | Biotechnology, Health Care, Medical Device, Medical | Late Stage Venture | 19M | United States, Connecticut |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.